These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
586 related items for PubMed ID: 12771987
1. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Br J Cancer; 2003 Jun 02; 88(11):1721-6. PubMed ID: 12771987 [Abstract] [Full Text] [Related]
2. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST. Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638 [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE. Cancer Res; 2000 Jun 01; 60(11):2898-905. PubMed ID: 10850435 [Abstract] [Full Text] [Related]
4. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Gasparini G, Toi M, Miceli R, Vermeulen PB, Dittadi R, Biganzoli E, Morabito A, Fanelli M, Gatti C, Suzuki H, Tominaga T, Dirix LY, Gion M. Cancer J Sci Am; 1999 Jun 01; 5(2):101-11. PubMed ID: 10198732 [Abstract] [Full Text] [Related]
5. Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480. George DJ, Halabi S, Shepard TF, Vogelzang NJ, Hayes DF, Small EJ, Kantoff PW, Cancer and Leukemia Group B 9480. Clin Cancer Res; 2001 Jul 01; 7(7):1932-6. PubMed ID: 11448906 [Abstract] [Full Text] [Related]
6. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY. Br J Cancer; 1999 May 01; 80(5-6):892-7. PubMed ID: 10360671 [Abstract] [Full Text] [Related]
7. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Coskun U, Günel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S, Ozkan S. Neoplasma; 2003 May 01; 50(1):41-6. PubMed ID: 12687277 [Abstract] [Full Text] [Related]
8. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [Abstract] [Full Text] [Related]
9. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M. Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286 [Abstract] [Full Text] [Related]
10. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ, Li JR, Li ZB. Int J Oral Maxillofac Surg; 2002 Oct 01; 31(5):495-8. PubMed ID: 12418564 [Abstract] [Full Text] [Related]
11. Anti-angiogenic activity of melatonin in advanced cancer patients. Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. Neuro Endocrinol Lett; 2001 Oct 01; 22(1):45-7. PubMed ID: 11335879 [Abstract] [Full Text] [Related]
12. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G. Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991 [Abstract] [Full Text] [Related]
14. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY. Gynecol Oncol; 1999 Aug 01; 74(2):235-40. PubMed ID: 10419737 [Abstract] [Full Text] [Related]
15. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG, Klijn JG. Cancer Res; 2001 Jul 15; 61(14):5407-14. PubMed ID: 11454684 [Abstract] [Full Text] [Related]
19. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer. Minagawa N, Nakayama Y, Hirata K, Onitsuka K, Inoue Y, Nagata N, Itoh H. Anticancer Res; 2002 Jan 15; 22(5):2957-63. PubMed ID: 12530025 [Abstract] [Full Text] [Related]
20. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Heer K, Kumar H, Read JR, Fox JN, Monson JR, Kerin MJ. Clin Cancer Res; 2001 Nov 15; 7(11):3491-4. PubMed ID: 11705867 [Abstract] [Full Text] [Related] Page: [Next] [New Search]